PropertyValue
?:abstract
  • Drug repositioning is a strategy that identifies new uses of approved drugs to treat conditions different from their original purpose. With the advance of COVID-19 and the pandemic declaration; It has become the closest alternative to reduce the advance of the virus. Antimalarial, antiviral drugs, antibiotics, glucocorticoids, monoclonal antibodies, among others, are being studied; their findings, although preliminary, could establish a starting point in the search for a solution. In this review, we present a selection of drugs, of different classes and with potential activity against COVID-19, whose trials are ongoing; and as proofs of concept, double blind, add-on event-driven, would allow proposing research that generates results in less time and preserving quality criteria for drug development and approval by regulatory agencies.
?:creator
?:doi
?:doi
  • 10.25100/cm.v51i2.4279
?:journal
  • Colombia_medica
?:license
  • cc-by-nc-nd
?:pdf_json_files
  • document_parses/pdf_json/f72cd8c2964139765256684719cfa077620a935c.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7518729.xml.json
?:pmcid
?:pmid
?:pmid
  • 33012890.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Drug Repositioning for COVID-19
?:type
?:year
  • 2020-06-30

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/hznnoxw6>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/hznnoxw6>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all